IHS Chemical Week

Regions :: Australia/New Zealand

Watson Pharmaceuticals Acquires Strides Arcolab’s Generics Business in Australia and Southeast Asia for $393 Million

2:22 AM MST | January 24, 2012 | Deepti Ramesh

Watson Pharmaceuticals (Parsippany, NJ) and Strides Arcolab (Bangalore, India) say that Watson has acquired Ascent Pharmahealth (Melbourne), the generic pharmaceutical business of Strides Arcolab in Australia and Southeast Asia for A$375 million ($393 million) in cash. Ascent is one of the top five generic pharmaceutical companies in Australia and is present across several countries in Southeast Asia, including Singapore where it is the leading generic pharmaceutical company. With the acquisition, Watson becomes the fifth largest generic pharma company in...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa